Monitoring neuroprotection and restorative therapies in Parkinson's disease with PET

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

In this article the role of functional imaging (PET and SPECT) as a surrogate marker for following the progression of Parkinson's disease (PD) is discussed. The potential value of PET and SPECT for assessing the efficacy of putative neuroprotective agents in PD is considered and a review of 18F-dopa PET findings in transplantation trials involving implantation of human and procine fetal mesencephalic tissue is presented. It is concluded that functional imaging provides a valuable adjunct to clinical assessment when judging the efficacy of neuroprotective and restorative approaches to PD.

Original languageEnglish
JournalJournal of Neural Transmission, Supplement
Pages (from-to)125-137
Number of pages13
Publication statusPublished - 1 Dec 2000
Externally publishedYes

See relations at Aarhus University Citationformats

ID: 132380632